The percentage of CD4+/CTLA-4+ lymphocytes ≤ 12.62% was a factor that significantly increased the probability of progression-free survival after the diagnosis of CLL (p = 0.008; Figure 3A). This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.